Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04294966 · ClinicalTrials.gov registry record · Early Phase 1

Age-Related Effects of THC

A Early Phase 1 study of Adolescent Behavior and THC, sponsored by University of Chicago.

Completed
Registry status
Early Phase 1
Development phase
24
Enrollment target
2
Study locations

NCT04294966 is a Early Phase 1 study of Adolescent Behavior and THC that has completed, run by University of Chicago. The registered enrollment target is 24 participants, below the 329-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04294966, a Early Phase 1 study of Adolescent Behavior and THC, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
Early Phase 1
Development phase
24 participants
Enrollment target
2
Study locations

Study Summary

Increased accessibility to cannabis and its primary psychoactive constituent THC has raised public health concerns. One major concern surrounds the potential risks associated with acute THC intoxication and who might be most at risk. A second major concern is the need to develop sensitive measures that can detect THC intoxication after recent use and enable robust comparisons of intoxication to determine sources of risk. One potential source of risk is age, specifically during the period of adolescence.

Interventions

  • DRUG Dronabinol
  • DRUG Dextrose

Study Locations (2)

Illinois

  • University of Chicago Hospital - Chicago
  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2020-03-10
Est. Completion 2021-05-01
Phase Early Phase 1

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT04294966

The ClinicalTrials.gov registry entry for NCT04294966 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (93% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Adolescent Behavior appearing as the primary indexed condition, and to 2 interventions - of which Dronabinol is the first listed.

NCT04294966 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04294966 about?

NCT04294966 is a clinical study titled "Age-Related Effects of THC". Increased accessibility to cannabis and its primary psychoactive constituent THC has raised public health concerns. One major concern surrounds the potential risks associated with acute THC intoxication and who might be most at risk. A second major concern is the need to develop sensitive measures t...

What is the current status of trial NCT04294966?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2020-03-10. Estimated completion is 2021-05-01.

What conditions does trial NCT04294966 study?

This clinical trial studies the following conditions: Adolescent Behavior, THC, Tolerance.

What interventions are being tested in trial NCT04294966?

The interventions under investigation include: Dronabinol (DRUG), Dextrose (DRUG).

Who is sponsoring clinical trial NCT04294966?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04294966 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.